» Articles » PMID: 29106619

NPASS: Natural Product Activity and Species Source Database for Natural Product Research, Discovery and Tool Development

Overview
Specialty Biochemistry
Date 2017 Nov 7
PMID 29106619
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

There has been renewed interests in the exploration of natural products (NPs) for drug discovery, and continuous investigations of the therapeutic claims and mechanisms of traditional and herbal medicines. In-silico methods have been employed for facilitating these studies. These studies and the optimization of in-silico algorithms for NP applications can be facilitated by the quantitative activity and species source data of the NPs. A number of databases collectively provide the structural and other information of ∼470 000 NPs, including qualitative activity information for many NPs, but only ∼4000 NPs are with the experimental activity values. There is a need for the activity and species source data of more NPs. We therefore developed a new database, NPASS (Natural Product Activity and Species Source) to complement other databases by providing the experimental activity values and species sources of 35 032 NPs from 25 041 species targeting 5863 targets (2946 proteins, 1352 microbial species and 1227 cell-lines). NPASS contains 446 552 quantitative activity records (e.g. IC50, Ki, EC50, GI50 or MIC mainly in units of nM) of 222 092 NP-target pairs and 288 002 NP-species pairs. NPASS, http://bidd2.nus.edu.sg/NPASS/, is freely accessible with its contents searchable by keywords, physicochemical property range, structural similarity, species and target search facilities.

Citing Articles

Computational framework for minimizing off-target toxicity in capecitabine treatment using natural compounds.

Jamal T, Ali A, Chauhan S, Singh R, Parthasarathi R Mol Divers. 2025; .

PMID: 40009148 DOI: 10.1007/s11030-025-11139-0.


Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms.

Marafie S, Alshawaf E, Al-Mulla F, Abubaker J, Mohammad A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770519 PMC: 11677242. DOI: 10.3390/ph17121677.


Osteoblastic ferroptosis inhibition by small-molecule promoting GPX4 activation for peri-prosthetic osteolysis therapy.

Liu X, Wang W, Zhu F, Xu H, Ge G, Liang X J Nanobiotechnology. 2024; 22(1):758.

PMID: 39696565 PMC: 11658433. DOI: 10.1186/s12951-024-03049-4.


NaCTR: Natural product-derived compound-based drug discovery pipeline from traditional oriental medicine by search space reduction.

Jung S, Kim K, Wang S, Han M, Lee D Comput Struct Biotechnol J. 2024; 23:3869-3877.

PMID: 39554615 PMC: 11564001. DOI: 10.1016/j.csbj.2024.10.035.


Accurate prediction of drug-target interactions in Chinese and western medicine by the CWI-DTI model.

Li Y, Zhang X, Chen Z, Yang H, Liu Y, Wang H Sci Rep. 2024; 14(1):25054.

PMID: 39443630 PMC: 11499656. DOI: 10.1038/s41598-024-76367-0.


References
1.
Wang Y, Bryant S, Cheng T, Wang J, Gindulyte A, Shoemaker B . PubChem BioAssay: 2017 update. Nucleic Acids Res. 2016; 45(D1):D955-D963. PMC: 5210581. DOI: 10.1093/nar/gkw1118. View

2.
Banerjee P, Erehman J, Gohlke B, Wilhelm T, Preissner R, Dunkel M . Super Natural II--a database of natural products. Nucleic Acids Res. 2014; 43(Database issue):D935-9. PMC: 4384003. DOI: 10.1093/nar/gku886. View

3.
Sharma A, Dutta P, Sharma M, Rajput N, Dodiya B, Georrge J . BioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts. J Cheminform. 2014; 6(1):46. PMC: 4206768. DOI: 10.1186/s13321-014-0046-2. View

4.
Tao L, Zhu F, Qin C, Zhang C, Xu F, Tan C . Nature's contribution to today's pharmacopeia. Nat Biotechnol. 2014; 32(10):979-80. DOI: 10.1038/nbt.3034. View

5.
Leonti M, Casu L . Traditional medicines and globalization: current and future perspectives in ethnopharmacology. Front Pharmacol. 2013; 4:92. PMC: 3722488. DOI: 10.3389/fphar.2013.00092. View